Maureen Dubreuil, MD, MSc.

Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Dubreuil is a rheumatologist in Boston, specializing in spondyloarthritis. She works within the Rheumatology section at Chobanian and Avedisian School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. Dr. Dubreuil's research has been funded by numerous competitive grants from funders including the NIH, private foundations and industry. Some highlights of Dr. Dubreuil's work includes:
1. Discovery of two key protective effects of TNF inhibitors against fractures and cardiovascular events in spondyloarthritis
2. Finding that a common nonsteroidal anti-inflammatory drug is associated with 3 times the risk of heart attack among people with spondyloarthritis
3. Development of the first North American guidelines for referral of adults at increased risk of having spondyloarthritis to a rheumatologist

In addition to her research, Dr. Dubreuil is a member of the leading international organizations for spondyloarthritis research. She serves on the Executive Committee of the Board of Directors for the Spondyloarthritis Research and Treatment Network, and on the Medical Advisory Board for the Spondylitis Association of America. She is a site investigator for the international CLASSIC study in spondyloarthritis. Dr. Dubreuil is the Director of Research Training for the Rheumatology Fellowship program at Boston Medical Center.

Dr. Dubreuil cares for people with rheumatic conditions at Boston Medical Center and the VA Boston Healthcare System. Dr. Dubreuil's patients say the following about her:
"Dr. Dubreuil is a very caring and knowledgeable doctor and it's always a pleasure to be seen by her."
"I am very satisfied with the care I have received. My provider and the support staff is very professional, caring and concerned. I would recommend to anyone."
"Dr. Dubreuil is a gem and I feel so lucky to have her!"
A survey of 40 patients who received care by Dr. Dubreuil in 2024-2025 found that 100% would recommend her!

Publications

  • Published 7/1/2026

    Nikiphorou E, Tillett W, Deodhar A, Dubreuil M, Gossec L, Hwang M, Lubrano E, Machado PM, Rudwaleit M, de Wit M, Kavanagh S, de la Loge C, Ink B, Healy P, Lambert J, Mørup M, Boonen A, Walsh J. Bimekizumab Improves Health Status and Work Productivity, With Reduced Productivity Costs, to 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis. J Rheumatol. 2026 Jul 01. PMID: 42386286.

    Read at: PubMed

  • Published 5/13/2026

    Navarro-Compán V, Kiltz U, Mease PJ, Dubreuil M, Gaffney K, Deodhar A, de la Loge C, Prajapati C, Kavanagh S, Marzo-Ortega H. Bimekizumab treatment for sustained improvements in patient symptoms and health-related quality of life to 3 years in axial spondyloarthritis: results from the BE MOBILE studies and their open-label extension. RMD Open. 2026 May 13; 12(2). PMID: 42128532.

    Read at: PubMed

  • Published 12/1/2025

    Choufani M, Ghusn W, Dubreuil M, Ermann J. Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region. J Rheumatol. 2025 Dec 01; 52(12):1245-1253. PMID: 40089303.

    Read at: PubMed

  • Published 11/28/2025

    Marzo-Ortega H, Navarro-Compan V, Dubreuil M, Mease PJ, Magrey M, Rudwaleit M, D'Agostino MA, Gaffney K, Kay J, de la Loge C, Massow U, Taieb V, Vaux T, Deodhar A. Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies. RMD Open. 2025 Nov 28; 11(4). PMID: 41314667.

    Read at: PubMed

  • Published 11/11/2025

    Petrow E, Meade-Aguilar JA, Peloquin C, Jafarzadeh SR, Neogi T, Dubreuil M, Liew J. Effect of Early Tumor Necrosis Factor Inhibitor Initiation on Chronic Opioid Use in Individuals With Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2026 Jan; 78(1):76-84. PMID: 41084285.

    Read at: PubMed

View All 85 Publications:   View Full Profile in BUMC

Other Positions

  • Member, Arthritis & Autoimmune Diseases Research Center
    Boston University

Websites

Education

  • University of Connecticut School of Medicine, MD
  • Boston University School of Public Health, MSc
  • Rochester Institute of Technology, BS

View all profiles